In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1853 News Items found
Sheree Scarlett
Feature
Sheree Scarlett: Celebrating Diversity and Staying True to Her Roots

Meet Sheree Scarlett, who helps to promote the wellness-related resources available to employees in her role in Employee Health and Wellness Services at MSK.
Learn about ashwagandha, an herb used for stress relief.
The Truth about Ashwagandha and Cancer: Answers from an MSK Expert

Learn about ashwagandha, an herb used for stress relief.
Cycle for Survival is a powerful fundraising phenomenon with the goal to beat rare cancers, raising nearly $300 million so far.
How Cycling Fights Cancer: Dave Linn & Ethan Zohn on the Power of Cycle for Survival

Cancer often leaves those it touches consumed with a feeling of hopelessness. But sometimes that feeling can motivate clinicians, patients, and supporters alike to turn soul-crushing moments into positive change.
Alexandra Joyner, Ming Li, and Kenneth Offit
Three Memorial Sloan Kettering Cancer Center Faculty Members Elected as 2021 AAAS Fellows

Three faculty members from Memorial Sloan Kettering Cancer Center (MSK) and Sloan Kettering Institute (SKI) have been elected to the 2021 class of American Association for the Advancement of Science (AAAS) Fellows.
Craig B. Thompson
Craig B. Thompson Named to City & State’s 2022 Health Care Power 100 List

Craig B. Thompson, MD, President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to City & State’s 2022 Health Care Power 100 list.
Man and woman looking at camera and smiling.
New MSK Radiation Approach Means Fewer Side Effects for More Patients with HPV-Related Head and Neck Cancer

A low-dose radiation approach could help more patients avoid side effects of treatment for head and neck cancer.
Lab worker dressed in “bunny suit” working with machine.
A New Immunotherapy Discovery: Putting a HIT on Elusive Cancer Cells

A new type of engineered immune cell could be a potent treatment for cancers that have escaped other immunotherapies.
Luis Parada in his lab
In the Lab
Why Do Brain Tumors Often Return After Treatment? MSK Researchers Say Stem Cells May Be Key

In a new study, MSK researchers looked at why glioblastoma brain tumors usually come back after treatment. Their findings suggest that a subset of cells — cancer stem cells — are able to evade current treatments because they are not actively dividing, and that these cells later form new tumors.
Memorial Sloan Kettering physician-scientist Michel Sadelain.
Clinical Trial for Beta-Thalassemia Brings Important Insights for Treating Blood Disorders with Stem Cell Gene Therapy

A gene therapy approach could prove effective at treating an inherited blood disorder called beta (β)-thalassemia.
Separate headshots of three researchers — Diana Mandelker, Jorge Reis-Filho, and Fresia Pareja
Feature
How a Mishap in Early Development Can Lead to a Lifetime of Cancer Risk

MSK researchers have found mutations that arise in embryos can convey a risk of cancer that’s similar to what’s seen in people with inherited cancer mutations.